Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
Clinical trial NCT01514526 · COMPLETED
Trial details
- NCT number
- NCT01514526
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.